Date | Insider | Price | Amount |
---|---|---|---|
11-24-2021 Insider Buy |
Vincent Milano Director |
$12.19 CAGR » |
$91,425.00 7,500 shares |
11-18-2019 Insider Buy |
Jon P. Stonehouse President & CEO |
$1.45 CAGR » |
$72,500.00 50,000 shares |
11-18-2019 Insider Buy |
Megan Sniecinski Chief Business Officer |
$1.45 CAGR » |
$65,250.00 45,000 shares |
11-18-2019 Insider Buy |
Theresa Heggie Director |
$1.45 CAGR » |
$7,250.00 5,000 shares |
11-18-2019 Insider Buy |
Yarlagadda S. Babu Senior VP - Drug Discovery |
$1.45 CAGR » |
$36,250.00 25,000 shares |
11-18-2019 Insider Buy |
Steve Aselage Director |
$1.45 CAGR » |
$21,750.00 15,000 shares |
11-18-2019 Insider Buy |
Nancy J. Hutson Director |
$1.45 CAGR » |
$14,500.00 10,000 shares |
11-18-2019 Insider Buy |
Robert Alexander Ingram Director |
$1.45 CAGR » |
$29,000.00 20,000 shares |
11-18-2019 Insider Buy |
Kenneth B. Lee Jr. Director |
$1.45 CAGR » |
$7,250.00 5,000 shares |
3-12-2019 Insider Buy |
Steve Aselage Director |
$8.30 CAGR » |
$16,600.00 2,000 shares |
2-5-2016 Insider Buy |
BROS. Advisors LP Baker >10% Owner |
$6.33 CAGR » |
$284,656.50 45,000 shares |
2-4-2016 Insider Buy |
BROS. Advisors LP Baker >10% Owner |
$6.43 CAGR » |
$1,336,586.04 207,715 shares |
1-28-2016 Insider Buy |
BROS. Advisors LP Baker >10% Owner |
$6.95 CAGR » |
$613,985.73 88,345 shares |
1-22-2016 Insider Buy |
BROS. Advisors LP Baker >10% Owner |
$7.28 CAGR » |
$777,757.44 106,800 shares |
1-20-2016 Insider Buy |
BROS. Advisors LP Baker >10% Owner |
$7.35 CAGR » |
$2,147,972.32 292,200 shares |
2-20-2015 Insider Buy |
Nancy J. Hutson Director |
$10.27 CAGR » |
$102,700.00 10,000 shares |
11-12-2013 Insider Buy |
George B. Abercrombie Director |
$6.19 CAGR » |
$18,570.00 3,000 shares |
8-1-2013 Insider Buy |
Felix Baker >10% Owner |
$4.40 CAGR » |
$5,000,001.60 1,136,364 shares |
3-5-2013 Insider Buy |
George B. Abercrombie Director |
$1.23 CAGR » |
$3,690.00 3,000 shares |
12-14-2012 Insider Buy |
Peder Jensen Director |
$1.51 CAGR » |
$30,200.00 20,000 shares |
6-5-2012 Insider Buy |
Peder Jensen Director |
$3.18 CAGR » |
$63,680.00 20,000 shares |
3-13-2012 Insider Buy |
Charles A. Sanders Director |
$5.20 CAGR » |
$10,400.00 2,000 shares |
5-12-2011 Insider Buy |
Peder Jensen Director |
$3.56 CAGR » |
$35,600.00 10,000 shares |
11-18-2011 Insider Buy |
Peder Jensen Director |
$2.75 CAGR » |
$27,500.00 10,000 shares |
Also See: Institutional Holders of BCRX
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 11/26/2021 | |
End date: | 04/18/2024 | |
Start price/share: | $12.48 | |
End price/share: | $4.50 | |
Dividends collected/share: | $0.00 | |
Total return: | -63.94% | |
Average Annual Total Return: | -34.72% | |
Starting investment: | $10,000.00 | |
Ending investment: | $3,605.74 | |
Years: | 2.39 |
BCRX Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent BCRX insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding BCRX
Free BCRX Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |